The $13.3M insider buying cluster, particularly the $13M purchase by Director Duggan, is a strong vote of confidence following the Q1 beat and accelerated pivotal trial. Monitor for further insider buying and trial enrollment updates.
Price Chart
Executive Summary
Two PLSE insiders, including CEO Paul LaViolette and Director Robert Duggan, collectively purchased $13.3M in open-market shares on May 11, 2026, at $19.69. This represents ~1.0% of the company's $1.3B market cap, a significant insider buying cluster that follows the Q1 earnings beat and accelerated clinical trial timeline.
Key Financial Metrics
Key Facts
- CEO Paul LaViolette purchased 15,000 shares for $295,350 on May 11, 2026.
- Director Robert Duggan purchased 660,233 shares for $13.0M on May 11, 2026.
- Total insider buying of $13.3M represents ~1.0% of PLSE's $1.3B market cap.
- Purchases occurred 7 days after Q1 2026 earnings beat (GAAP net loss of $18.6M, -$0.27 EPS vs consensus -$0.32).
- Company accelerated pivotal NANOPULSE-AF trial enrollment to early Q4 2026.
- All transactions were open-market purchases (code P) — not grants or tax withholdings.
Financial Impact
Insider buying of $13.3M at $19.69/share, representing ~1.0% of market cap.
Risk Factors
- Company remains pre-revenue with $0.4M quarterly revenue and $18.6M net loss — cash burn continues.
- Pivotal trial enrollment acceleration to Q4 2026 is positive but still carries clinical and regulatory risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PLSE-1778540037675 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $46.32 | awaiting T+60 | — | $52.90 (+14.21%) |
Oct 7, 2026 20d ago | 8-K | $49.09 | awaiting T+60 | — | $52.90 (+7.76%) |
Sep 15, 2026 6w ago | 8-K | $55.20 | awaiting T+60 | — | $52.90 (−4.17%) |
Aug 6, 2026 11w ago | 8-K | $42.41 | awaiting T+60 | — | $52.90 (−24.73%) |
Aug 6, 2026 11w ago | 424B5 | $42.41 | awaiting T+60 | — | $52.90 (−24.73%) |
Jul 29, 2026 12w ago | 8-K | $34.25 $52.68 | ▲ +53.81% | ▲ +49.08% | $52.90 (+54.45%) |
Jun 12, 2026 19w ago | Institutional Cluster | $24.37 $48.79 | ▲ +100.21% | ▲ +96.94% | $52.90 (+117.07%) |
Jun 10, 2026 19w ago | 8-K | $24.99 $54.71 | ▲ +118.93% | ▲ +112.35% | $52.90 (+111.68%) |
May 15, 2026 23w ago | Insider Cluster | $25.61 $43.32 | ▲ +69.15% | ▲ +64.30% | $52.90 (+106.56%) |
May 11, 2026 24w ago | Insider Cluster | $19.08 $37.90 | ▲ +98.64% | ▲ +94.24% | $52.90 (+177.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers